Article
Key genes and molecular mechanisms related to Paclitaxel Resistance
13 Jul 2024
Abstract excerpt
Paclitaxel is commonly used to treat breast, ovarian, lung, esophageal, gastric, pancreatic cancer, and neck cancer cells. Cancer recurrence is observed in patients treated with paclitaxel due to paclitaxel resistance emergence. Resistant mechanisms are observed in cancer cells treated with paclitaxel, docetaxel, and cabazitaxel including changes in the target molecule β-tubulin of mitosis, molecular mechanisms...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
